Webinars

Covers essential analytical tools for AAV drug product stability assessment.

Explores how strategic formulation enhances biosimilar quality, stability, and market edge.

Outlines fundamental principles and strategies for effective formulation development.

Highlights early developability assessments for successful biotherapeutic clinical and commercial progression.

Focuses on developing stable, manufacturable highly concentrated liquid protein formulations.

Presents strategies for dry-state stabilization of enveloped viruses.

Discusses challenges and strategies for high-concentration biologic formulations

Addresses challenges of high-concentration SubQ formulations, especially protein aggregation.

Examines how early formulation and characterization are key to faster, safer drug development.

Introduces "ExPreSo": a data science tool combining formulation expertise and machine learning.

Innovative formulations to stabilize lyophilized oncolytic viruses, overcoming deep-frozen challenges.